英文名称 | Il-94 |
---|
IUPAC Name | 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-N-[(6-fluoro-1H-indazol-4-yl)methyl]-2-N-(2-methoxyethyl)pyrimidine-2,4-diamine |
---|---|
INCHI | InChI=1S/C21H23FN8O/c1-31-7-6-30(12-14-8-15(22)9-18-16(14)11-24-27-18)21-23-5-4-19(26-21)25-20-10-17(28-29-20)13-2-3-13/h4-5,8-11,13H,2-3,6-7,12H2,1H3,(H,24,27)(H2,23,25,26,28,29) |
InChi Key | FTGUWURNNBVUBC-UHFFFAOYSA-N |
Canonical SMILES | COCCN(c1nccc(n1)Nc1n[nH]c(c1)C1CC1)Cc1cc(F)cc2c1cn[nH]2 |
PubChem CID | 73348907 |
ChEMBL Ligand | CHEMBL2386715 |
---|---|
PubChem CID | 73348907 |
Ligand ID | 8132 |
---|---|
名称 | Il-94 |
类别 | Synthetic organic |
学名 | 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-N-[(6-fluoro-1H-indazol-4-yl)methyl]-2-N-(2-methoxyethyl)pyrimidine-2,4-diamine |
生物活性评价 |
The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in |
评价 |
Il-94 is a PAK1 (p21 protein (Cdc42/Rac)-activated kinase 1) inhibitor |
1. Abdel-Magid AF. (2013) PAK1: A Therapeutic Target for Cancer Treatment.. ACS Med Chem Lett, 4 (5): (431-2). [PMID:24900689] |